Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma V. Petley
Observed names:
EV Petley,
Emma V Petley,
Petley, Emma Victoria
Institutions:
The University of Melbourne,
Walter and Eliza Hall Institute of Medical Research
Observed institutions:
The University of Melbourne,
Walter and Eliza Hall Institute of Medical Research,
Malaghan Institute of Medical Research,
Peter MacCallum Cancer Centre
ORCID:
0000-0002-2527-269X
Observed ORCID:
0000-0002-2527-269X
OpenAlex ID:
A5035657197
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
2019
·
Imran G. House
, Peter Savas
, et al.
·
Clinical Cancer Research
·
856
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
2024
·
Jack D. Chan
, Christina M. Scheffler
, et al.
·
Nature
·
283
PDF
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
2021
·
Lauren Giuffrida
, Kevin Sek
, et al.
·
Nature Communications
·
254
PDF
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
2020
·
Junyun Lai
, Sherly Mardiana
, et al.
·
Nature Immunology
·
237
MAIT cells regulate NK cell-mediated tumor immunity
2021
·
Emma V. Petley
, Hui-Fern Koay
, et al.
·
Nature Communications
·
120
PDF
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors
2020
·
Lauren Giuffrida
, Kevin Sek
, et al.
·
Molecular Therapy
·
113
PDF
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2018
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
·
Cancer Immunology Research
·
78
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors
2025
·
Kevin Sek
, Amanda X. Y. Chen
, et al.
·
Nature Communications
·
18
PDF
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity
2023
·
Imran G. House
, Emily B. Derrick
, et al.
·
Cell Reports
·
16
PDF
A2AR eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses
2023
·
Kirsten L. Todd
, Junyun Lai
, et al.
·
Nature Communications
·
14
PDF
Differential location of NKT and MAIT cells within lymphoid tissue
2022
·
Darryl N. Johnson
, Zheng Ruan
, et al.
·
Scientific Reports
·
14
PDF
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity
2024
·
Imran G. House
, Emily B. Derrick
, et al.
·
Cell Reports
·
7
Tumor‐derived exosomes modulate T cell function through transfer of RNA
2018
·
Imran G. House
, Emma V. Petley
, et al.
·
FEBS Journal
·
6
PDF
A novel combination strategy for effectively targeting cancer stem‐like cells
2017
·
Paul A Beavis
, Emma V Petley
, et al.
·
Immunology and Cell Biology
·
6
PDF
The Synthesis and Anti‐tumour Properties of Poly Ethoxy Ethyl Glycinamide (PEE−G) Scaffolds with Multiple PD‐1 Peptides Attached
2020
·
Rinu Shrestha
, Emma V. Petley
, et al.
·
ChemMedChem
·
4
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression
2026
·
Esther Bandala-Sanchez
, Emma V. Petley
, et al.
·
Blood
·
1
Figure S3 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
2023
·
Imran G. House
, Peter Savas
, et al.
·
1
Data from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
Data from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
Figure S1 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
Figure S5 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
Figure S2 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
Figure S4 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
PDF
Figure S2 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
PDF
Figure S3 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
2023
·
Paul A. Beavis
, Melissa A. Henderson
, et al.
PDF
Show more works
View as search
Works count:
45
Citation count:
2,028
H-index:
11
I10-index:
11
Year
Topic
Type